Company Biophytis S.A. Euronext Paris

Equities

ALBPS

FR0012816825

Biotechnology & Medical Research

End-of-day quote Euronext Paris 06:00:00 2024-05-06 pm EDT 5-day change 1st Jan Change
0.85 EUR -.--% Intraday chart for Biophytis S.A. +1.19% -58.33%

Business Summary

Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.

The company is located in Paris, France and Cambridge, Massachusetts.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,601,206 1,055,663 ( 40.58 %) 600 ( 0.0231 %) 40.58 %

Shareholders

NameEquities%Valuation
32,775,471 2.333 % 73 745 €
Gestys SA
1.593 %
22,380,000 1.593 % 50 355 €
Waly Dioh
0.0175 %
246,316 0.0175 % 554 €
Lyxor International Asset Management SAS
0.0169 %
236,829 0.0169 % 533 €
142,308 0.0101 % 320 €
Ecofi Investissements SA
0.007545 %
105,980 0.007545 % 238 €
Rob van Maanen
0.005409 %
75,983 0.005409 % 171 €
75,983 0.005409 % 171 €
Claresco Finance SA
0.002086 %
29,300 0.002086 % 66 €
Nadine Coulm
0.000089 %
1,250 0.000089 % 3 €
NameEquities%Valuation
UBS Securities LLC
0.005126 %
18 0.005126 % 148 €
RhumbLine Advisers LP
0.003702 %
13 0.003702 % 107 €

Company contact information

Biophytis SA

Sorbonne Université Bâtiment A 4 ème étage

75005, Paris

+33 1 44 27 23 00

http://www.biophytis.com
address Biophytis S.A.(ALBPS)